NGM

NGM Biopharmaceuticals, Inc. Common Stock
NGM

Overview Fund Activity
Delisted

NGM was delisted on the 4th of April, 2024.

Back to rankings

73 hedge funds and large institutions have $403M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 4 closing their positions.

Holders
73
Holders Change
+14
Holders Change %
+23.73%
% of All Funds
1.61%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
18
Increased
25
Reduced
16
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ACM
1
Aquilo Capital Management
California
$12.9M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$12.3M
3
PS
3
Peter Svennilson
$214M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$2.82M
5
Citadel Advisors
5
Citadel Advisors
Florida
$2.53M

Top Sellers

1
Nuveen Asset Management
1
Nuveen Asset Management
Illinois
$1.41M
2
OAM
2
Oxford Asset Management
United Kingdom
$0
3
BlackRock
3
BlackRock
New York
$27.8M
4
Morgan Stanley
4
Morgan Stanley
New York
$35K
5
Goldman Sachs
5
Goldman Sachs
New York
$549K
Name Market Value Shares Shares
Change 		Shares
Change %
PCM
76
Pentwater Capital Management
Florida
– – -10,000 Closed
GWS
77
Glassman Wealth Services
Virginia
– – -15 Closed
CFGS
78
Concourse Financial Group Securities
Alabama
– – – –
1 2 3
4